Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
-3.06% $3.80
America/New_York / 28 mar 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 62.22 mill |
EPS: | 0.0300 |
P/E: | 126.67 |
Earnings Date: | Apr 30, 2024 |
SharesOutstanding: | 16.37 mill |
Avg Daily Volume: | 0.168 mill |
RATING 2024-03-28 |
---|
A |
Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Sell | |
Return On Equity: | Strong Buy | |
Return On Asset: | Strong Buy | |
DE: | Sell | |
P/E: | Strong Buy | |
Price To Book: | Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE 126.67 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
0.57x |
Company: PE 126.67 | industry: PE 222.16 |
DISCOUNTED CASH FLOW VALUE |
---|
$-0.721 (-118.98%) $-4.52 |
Date: 2024-03-28 |
Expected Trading Range (DAY) |
---|
$ 3.51 - 4.09 ( +/- 7.74%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-11 | Sardano Michael | Buy | 20 000 | Common Stock |
2023-12-19 | Martinez Magdalena | Sell | 741 | Common Stock |
2023-09-14 | Sardano Joseph C | Buy | 10 000 | Common Stock |
2023-08-28 | Sardano Michael | Buy | 1 000 | Common Stock |
2023-08-08 | Sardano Michael | Buy | 1 000 | Common Stock |
INSIDER POWER |
---|
26.74 |
Last 96 transactions |
Buy: 257 000 | Sell: 578 831 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $3.80 (-3.06% ) |
Volume | 0.0510 mill |
Avg. Vol. | 0.168 mill |
% of Avg. Vol | 30.35 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.